MedTrace Logo

Clinical Feature and Microbiology Characteristics of Empyema in Children

NCT04695275 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-01-05

No results posted yet for this study

Summary

The study is designed to clarify the clinical characteristics and reversion of children with empyema, observe the effect of streptococcus vaccine application on serotype of streptococcus, and to explore the susceptibility factors of streptococcus empyema in children in China.

Conditions

  • Empyema

Sponsors & Collaborators

  • Capital Institute of Pediatrics, China

    collaborator OTHER

  • Tianjin Children's Hospital

    collaborator OTHER

  • Second Hospital affiliated with Tianjin Medical University

    collaborator UNKNOWN

  • Children's Hospital of Hebei Province

    collaborator OTHER

  • Baoding Children's Hospital

    collaborator OTHER

  • Beijing Children's Hospital

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-06
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04695275 on ClinicalTrials.gov